Notes to the Company financial statements continued For the year ended 30 June 2025
52. Share capital, share premium account and other reserves The movements in share capital, share premium and other reserves during the financial year were as follows:
53. Reconciliation of operating profit to net cash inflow from operating activities
2025 £’000 4,699
2024 £’000 12,308
Share premium account £’000
Number of shares
Share capital £’000
Other reserves £’000
Operating profit
Total £’000 82,186
Adjustments for: Decrease in payables
At 1 July 2023
16,399,663
164
81,830
192
8,791
15,512
Shares issued: on exercise of options
(761)
(Increase)/decrease in receivables
94
8,554
–
135 545
– –
135 546
409
Share-based payments
374
to SAYE Scheme
35,488
1
(25)
Change in fair value of financial assets through P&L Change in fair value of deferred consideration payable
– –
of consideration for business combinations
422
28,748
–
625
–
625
–
Impairment of investment in subsidiary Net cash inflow from operating activities
6,074
At 30 June 2024
16,472,453
165
83,135
192
83,492
13,535
34,362
Shares issued: on exercise of options
699
– –
16
– –
16
54. Related-party transactions The remuneration of key personnel of the Company, defined as the Company’s Directors, is set out below:
4,714
130
130
to SAYE Scheme
of consideration for business combinations Shares cancelled on buybacks
42,673
–
706
– 5
706
(464,000) 16,056,539
(5)
–
-
84,344
At 30 June 2025
160
83,987
197
2025 £’000 2,218
2024 £’000
The total number of ordinary shares, issued and fully paid at 30 June 2025, was 16,056,539 (2024: 16,472,453) with a par value of 1p per share. Excluding 437,374 (2024: 421,938) shares held by the EBT, the Company had 15,619,165 (2024: 16,050,515) ordinary 1p shares in issue as at 30 June 2025. Details of the shares issued are given in note 32 of the consolidated financial statements. On 28 January 2025, the Company announced the commencement of a share buyback programme in respect of its shares having an aggregate value of up to £10 million. The shares are being purchased in the open market and upon cancellation, the par value is transferred from the share capital to the capital redemption reserve (within other reserves, refer to note 31). During the period from announcement to 30 June 2025, the Company has repurchased 464,000 shares for a total consideration of £6,970,000. The par value of share capital of £4,640 for these repurchases has transferred to the capital redemption reserve and the remaining amounts have reduced retained earnings by £6,966,000. At the date of signing this report, a further 74,000 shares were purchased and cancelled, for additional total consideration of £1,178,000. The Board will continue to deploy the remainder of the £10 million buyback in due course. Employee Benefit Trust Details of the EBT are set out in note 32 of the consolidated financial statements.
Short-term employee benefits Post-employment benefits
2,227
44 60
44 64
Share-based payments Total compensation
2,322
2,335
Dividends totalling £7,000 (2024: £34,000) were paid in the financial year in respect of ordinary shares held by key management personnel and their close family members. During the financial year, the Company entered into the following transactions with its subsidiaries:
2025 £’000
2024 £’000
Dividends received: Brooks Macdonald Asset Management Limited Cornelian Asset Managers Group Limited Levitas Investment Management Services Limited
14,000
24,500
– –
–
300
Total transactions with subsidiaries
14,000
24,800
160
Brooks Macdonald Group plc Annual Report and Accounts 2025
Made with FlippingBook - professional solution for displaying marketing and sales documents online